| 1B2T | A:0-76 | SOLUTION STRUCTURE OF THE CX3C CHEMOKINE DOMAIN OF FRACTALKINE |
| 1B50 | A:1-69; B:1-69 | NMR STRUCTURE OF HUMAN MIP-1A D26A, 10 STRUCTURES |
| 1B53 | A:1-69; B:1-69 | NMR STRUCTURE OF HUMAN MIP-1A D26A, MINIMIZED AVERAGE STRUCTURE |
| 1BO0 | A:1-76 | MONOCYTE CHEMOATTRACTANT PROTEIN-3, NMR, MINIMIZED AVERAGE STRUCTURE |
| 1DOK | A:0-71; B:0-71 | MONOCYTE CHEMOATTRACTANT PROTEIN 1, P-FORM |
| 1DOL | A:0-70 | MONOCYTE CHEMOATTRACTANT PROTEIN 1, I-FORM |
| 1DOM | A:1-76; B:1-76 | SOLUTION STRUCTURE OF THE MONOCYTE CHEMOATTRACTANT PROTEIN-1 DIMER USING HETERONUCLEAR, NMR, MINIMIZED AVERAGE STRUCTURE |
| 1DON | A:1-76; B:1-76 | SOLUTION STRUCTURE OF THE MONOCYTE CHEMOATTRACTANT PROTEIN-1 DIMER USING HETERONUCLEAR, NMR, 20 STRUCTURES |
| 1EIG | A:1-73 | SOLUTION STRUCTURE OF THE HUMAN CHEMOKINE EOTAXIN-2 |
| 1EIH | A:1-73 | SOLUTION STRUCTURE OF THE HUMAN CHEMOKINE EOTAXIN-2 |
| 1EOT | A:1-74 | SOLUTION NMR STRUCTURE OF EOTAXIN, MINIMIZED AVERAGE STRUCTURE |
| 1EQT | A:2-68; B:2-68 | MET-RANTES |
| 1ESR | A:2-76 | CRYSTAL STRUCTURE OF HUMAN MONOCYTE CHEMOTACTIC PROTEIN-2 |
| 1F2L | A:5-68; B:5-68; C:5-68; D:5-74 | CRYSTAL STRUCTURE OF CHEMOKINE DOMAIN OF FRACTALKINE |
| 1F9P | A:6-86 | CRYSTAL STRUCTURE OF CONNECTIVE TISSUE ACTIVATING PEPTIDE-III(CTAP-III) COMPLEXED WITH POLYVINYLSULFONIC ACID |
| 1F9Q | D:305-370; A:7-70; B:109-170; C:209-270 | CRYSTAL STRUCTURE OF PLATELET FACTOR 4 |
| 1F9R | A:6-70; C:206-270; D:306-370; B:108-170 | CRYSTAL STRUCTURE OF PLATELET FACTOR 4 MUTANT 1 |
| 1F9S | A:5-70; D:306-370; B:109-170; C:209-270 | CRYSTAL STRUCTURE OF PLATELET FACTOR 4 MUTANT 2 |
| 1G2S | A:1-71 | SOLUTION STRUCTURE OF EOTAXIN-3 |
| 1G2T | A:1-71 | SOLUTION STRUCTURE OF EOTAXIN-3 |
| 1G91 | A:1-77 | SOLUTION STRUCTURE OF MYELOID PROGENITOR INHIBITORY FACTOR-1 (MPIF-1) |
| 1HRJ | A:1-68; B:1-68 | HUMAN RANTES, NMR, 13 STRUCTURES |
| 1HUM | A:1-69; B:1-69 | SOLUTION STRUCTURE OF THE CHEMOKINE HMIP-1BETA(SLASH)ACT-2 BY MULTI-DIMENSIONAL NMR: A NOVEL CHEMOKINE DIMER |
| 1HUN | A:1-69; B:1-69 | SOLUTION STRUCTURE OF THE CHEMOKINE HMIP-1BETA(SLASH)ACT-2 BY MULTI-DIMENSIONAL NMR: A NOVEL CHEMOKINE DIMER |
| 1ICW | B:7-72; A:4-72 | INTERLEUKIN-8, MUTANT WITH GLU 38 REPLACED BY CYS AND CYS 50 REPLACED BY ALA |
| 1IKL | A:4-72 | NMR STUDY OF MONOMERIC HUMAN INTERLEUKIN-8 (MINIMIZED AVERAGE STRUCTURE) |
| 1IKM | A:4-72 | NMR STUDY OF MONOMERIC HUMAN INTERLEUKIN-8 (30 STRUCTURES) |
| 1IL8 | A:2-72; B:2-72 | THREE-DIMENSIONAL STRUCTURE OF INTERLEUKIN 8 IN SOLUTION |
| 1ILP | A:2-72; B:2-72 | CXCR-1 N-TERMINAL PEPTIDE BOUND TO INTERLEUKIN-8 |
| 1ILQ | A:2-72; B:2-72 | CXCR-1 N-TERMINAL PEPTIDE BOUND TO INTERLEUKIN-8 (MINIMIZED MEAN) |
| 1J8I | A:1-93 | SOLUTION STRUCTURE OF HUMAN LYMPHOTACTIN |
| 1J9O | A:1-93 | SOLUTION STRUCTURE OF HUMAN LYMPHOTACTIN |
| 1JE4 | A:1-69 | SOLUTION STRUCTURE OF THE MONOMERIC VARIANT OF THE CHEMOKINE MIP-1BETA |
| 1MGS | A:1-73; B:1-73 | THE SOLUTION STRUCTURE OF MELANOMA GROWTH STIMULATING ACTIVITY |
| 1MSG | A:1-72; B:1-72 | SOLUTION STRUCTURE OF GRO(SLASH)MELANOMA GROWTH STIMULATORY ACTIVITY DETERMINED BY 1H NMR SPECTROSCOPY |
| 1MSH | A:1-72; B:1-72 | SOLUTION STRUCTURE OF GRO(SLASH)MELANOMA GROWTH STIMULATORY ACTIVITY DETERMINED BY 1H NMR SPECTROSCOPY |
| 1NAP | A:21-86; B:21-86; D:21-86; C:24-86 | THE CRYSTAL STRUCTURE OF RECOMBINANT HUMAN NEUTROPHIL-ACTIVATING PEPTIDE-2 (M6L) AT 1.9-ANGSTROMS RESOLUTION |
| 1NCV | A:1-76; B:1-76 | DETERMINATION CC-CHEMOKINE MCP-3, NMR, 7 STRUCTURES |
| 1PFM | A:3-70; B:3-70; C:3-70; D:3-70 | PF4-M2 CHIMERIC MUTANT WITH THE FIRST 10 N-TERMINAL RESIDUES OF R-PF4 REPLACED BY THE N-TERMINAL RESIDUES OF THE IL8 SEQUENCE. MODELS 1-15 OF A 27-MODEL SET. |
| 1PFN | A:3-70; B:3-70; C:3-70; D:3-70 | PF4-M2 CHIMERIC MUTANT WITH THE FIRST 10 N-TERMINAL RESIDUES OF R-PF4 REPLACED BY THE N-TERMINAL RESIDUES OF THE IL8 SEQUENCE. MODELS 16-27 OF A 27-MODEL SET. |
| 1QE6 | C:6-72; A:5-72; B:2-72; D:1-72 | INTERLEUKIN-8 WITH AN ADDED DISULFIDE BETWEEN RESIDUES 5 AND 33 (L5C/H33C) |
| 1QG7 | B:2-67; A:6-67 | STROMA CELL-DERIVED FACTOR-1ALPHA (SDF-1ALPHA) |
| 1QNK | A:5-73; B:5-73 | TRUNCATED HUMAN GROB[5-73], NMR, 20 STRUCTURES |
| 1RHP | A:7-70; B:7-70; C:7-70; D:7-70 | CRYSTAL STRUCTURE OF RECOMBINANT HUMAN PLATELET FACTOR 4 |
| 1RTN | A:1-68; B:1-68 | PROTON NMR ASSIGNMENTS AND SOLUTION CONFORMATION OF RANTES, A CHEMOKINE OF THE CC TYPE |
| 1RTO | A:1-68; B:1-68 | PROTON NMR ASSIGNMENTS AND SOLUTION CONFORMATION OF RANTES, A CHEMOKINE OF THE CC TYPE |
| 1SDF | A:1-67 | SOLUTION STRUCTURE OF STROMAL CELL-DERIVED FACTOR-1 (SDF-1), NMR, MINIMIZED AVERAGE STRUCTURE |
| 1TVX | A:23-86; C:23-86; B:16-86; D:16-86 | NEUTROPHIL ACTIVATING PEPTIDE-2 VARIANT FORM M6L WITH FIVE ADDITIONAL AMINO TERMINAL RESIDUES (DSDLY) |
| 1U4L | A:2-68; B:4-68 | HUMAN RANTES COMPLEXED TO HEPARIN-DERIVED DISACCHARIDE I-S |
| 1U4M | A:2-68; B:4-68 | HUMAN RANTES COMPLEXED TO HEPARIN-DERIVED DISACCHARIDE III-S |
| 1U4P | B:2-67; A:1-67 | CRYSTAL STRUCTURE OF HUMAN RANTES MUTANT K45E |
| 1U4R | B:1-68; D:1-68; C:5-68; A:4-67 | CRYSTAL STRUCTURE OF HUMAN RANTES MUTANT 44-AANA-47 |
| 1VMC | A:8-68 | STROMA CELL-DERIVED FACTOR-1ALPHA (SDF-1ALPHA) |
| 2EOT | A:1-74 | SOLUTION STRUCTURE OF EOTAXIN, AN ENSEMBLE OF 32 NMR SOLUTION STRUCTURES |
| 2FMM | D:110-175; B:109-175; C:109-175; A:108-175 | CRYSTAL STRUCTURE OF EMSY-HP1 COMPLEX |
| 2HCC | A:1-66 | SOLUTION STRUCTURE OF THE HUMAN CHEMOKINE HCC-2, NMR, 30 STRUCTURES |
| 2HDM | A:2-75 | SOLUTION STRUCTURE OF V21C/V59C LYMPHOTACTIN/XCL1 |
| 2IL8 | A:2-72; B:2-72 | THREE-DIMENSIONAL STRUCTURE OF INTERLEUKIN 8 IN SOLUTION |
| 2K01 | A:1-68; C:201-268 | STRUCTURE OF A LOCKED SDF1 DIMER |
| 2K03 | A:1-68; C:201-268 | STRUCTURE OF SDF1 IN COMPLEX WITH THE CXCR4 N-TERMINUS CONTAINING A SULFOTYROSINE AT POSTITION 21 |
| 2K04 | A:1-68; C:201-268 | STRUCTURE OF SDF1 IN COMPLEX WITH THE CXCR4 N-TERMINUS CONTAINING NO SULFOTYROSINES |
| 2K05 | A:1-68; C:201-268 | STRUCTURE OF SDF1 IN COMPLEX WITH THE CXCR4 N-TERMINUS CONTAINING SULFOTYROSINES AT POSTITIONS 7, 12 AND 21 |
| 2K1B | A:1-55 | SOLUTION NMR STRUCTURE OF THE CHROMO DOMAIN OF THE CHROMOBOX PROTEIN HOMOLOG 7 |
| 2K28 | A:1-60 | SOLUTION NMR STRUCTURE OF THE CHROMO DOMAIN OF THE CHROMOBOX PROTEIN HOMOLOG 4 |
| 2KEC | A:1-68 | STRUCTURE OF SDF-1/CXCL12 |
| 2KED | A:1-68 | STRUCTURE OF SDF-1/CXCL12 |
| 2KEE | A:1-68 | STRUCTURE OF SDF-1/CXCL12 |
| 2L11 | A:1-54 | SOLUTION NMR STRUCTURE OF THE CBX3 IN COMPLEX WITH H3K9ME3 PEPTIDE |
| 2L12 | A:1-56 | SOLUTION NMR STRUCTURE OF THE CHROMOBOX PROTEIN 7 WITH H3K9ME3 |
| 2L1B | A:1-56 | SOLUTION NMR STRUCTURE OF THE CHROMOBOX PROTEIN CBX7 WITH H3K27ME3 |
| 2NWG | A:0-67; B:4-67 | STRUCTURE OF CXCL12:HEPARIN DISACCHARIDE COMPLEX |
| 2Q8R | E:1-66; F:1-63; G:1-63; H:1-63 | STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF CC CHEMOKINE CCL14 |
| 2Q8T | B:10-74; C:10-74; D:10-73; A:10-71 | CRYSTAL STRUCTURE OF THE CC CHEMOKINE CCL14 |
| 2RA4 | A:3-67; B:3-67 | CRYSTAL STRUCTURE OF HUMAN MONOCYTE CHEMOATTRACTANT PROTEIN 4 (MCP-4/CCL13) |
| 2SDF | A:1-67 | SOLUTION NMR STRUCTURE OF STROMAL CELL-DERIVED FACTOR-1 (SDF-1), 30 STRUCTURES |
| 2VXW | A:0-68; B:0-68; C:6-68; D:7-68 | STRUCTURAL AND FUNCTIONAL STUDIES OF THE POTENT ANTI-HIV CHEMOKINE VARIANT P2-RANTES |
| 3F2U | A:1-51 | CRYSTAL STRUCTURE OF HUMAN CHROMOBOX HOMOLOG 1 (CBX1) |
| 3FDT | A:2-52 | CRYSTAL STRUCTURE OF THE COMPLEX OF HUMAN CHROMOBOX HOMOLOG 5 (CBX5) WITH H3K9(ME)3 PEPTIDE |
| 3GV3 | A:5-67 | CXCL12 (SDF) IN TRIGONAL SPACE GROUP |
| 3GV6 | A:8-63 | CRYSTAL STRUCTURE OF HUMAN CHROMOBOX HOMOLOG 6 (CBX6) WITH H3K9 PEPTIDE |
| 3H91 | A:9-60; B:9-60 | CRYSTAL STRUCTURE OF THE COMPLEX OF HUMAN CHROMOBOX HOMOLOG 2 (CBX2) AND H3K27 PEPTIDE |
| 3HP3 | F:3-67; G:3-67; I:3-67; A:4-67; C:4-67; D:4-67; H:4-67; J:4-66; B:4-65; E:4-64 | CRYSTAL STRUCTURE OF CXCL12 |
| 3I3C | B:14-73; A:13-72; C:14-72; D:14-72 | CRYSTAL STRUCTURAL OF CBX5 CHROMO SHADOW DOMAIN |
| 3I90 | A:9-58 | CRYSTAL STRUCTURE OF HUMAN CHROMOBOX HOMOLOG 6 (CBX6) WITH H3K27 PEPTIDE |
| 3IL8 | A:5-72 | CRYSTAL STRUCTURE OF INTERLEUKIN 8: SYMBIOSIS OF NMR AND CRYSTALLOGRAPHY |
| 3KUP | B:112-173; D:114-173; A:114-172; C:112-172 | CRYSTAL STRUCTURE OF THE CBX3 CHROMO SHADOW DOMAIN |
)
)